TY - JOUR
TI - Switching to amisulpride monotherapy for treatment-resistant
schizophrenia
AU - Kontaxakis, VP
AU - Havaki-Kontaxaki, BJ
AU - Ferentinos, PP
AU - Paplos,
AU - KG
AU - Soldatos, CR
JO - European Psychiatry
PY - 2006
VL - 21
TODO - 3
SP - 214-217
PB - ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
SN - 0924-9338
TODO - 10.1016/j.eurpsy.2006.01.013
TODO - schizophrenia; antipsychotics; treatment resistance; amisulpride
TODO - The objective of this study was to assess switching to amisulpride (AMS)
in treatment-resistant schizophrenia. Seven mate subjects were switched
to AMS and followed for 8 weeks. PANSS scores improved from 123 to 66
over this period. We conclude that AMS is of interest in the treatment
of refractory schizophrenia. (c) 2006 Elsevier SAS. All rights reserved.
ER -